Amylyx Pharmaceuticals
The Associate Director of Quality Control leads the commercial Quality Control function, ensuring inspection-ready and globally compliant operations within a fully outsourced manufacturing and testing network. This role oversees commercial stability programs, specification lifecycle management, and analytical method validation across external partners. The position requires cross-functional collaboration to support commercial lot release, global market supply, and regulatory filing commitments.
Headquarters
Cambridge, Massachusetts, United States
Company Size
201-500 employees
Amylyx Pharmaceuticals is a biopharmaceutical company focused on developing novel therapies for diseases with high unmet needs, including Post-Bariatric Hypoglycemia (PBH), Wolfram Syndrome, and Amyotrophic Lateral Sclerosis (ALS). Its lead program, Avexitide, is being evaluated in the pivotal Phase 3 LUCIDITY clinical trial for PBH. Amylyx advances its pipeline using rigorous science, well-defined mechanistic rationale, and a strong commitment to the patient communities it serves.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amylyx Pharmaceuticals.
Wall Street Zen Upgrades Amylyx Pharmaceuticals (NASDAQ:AMLX) Stock Rating
4 days ago
Director of Global Quality Control
Scholar Rock
Quality Control
Aleap India
Analytical Development Scientist / Quality Control
BridgeBio Pharma
Analytical Development / QC Manager
Revolution Medicines
Specialist, Quality Control Analytical
ImmunityBio
Director, Quality Control (contractor)
Centessa Pharmaceuticals